A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology.

[1]  J. DeFelipe,et al.  The influence of phospho-tau on dendritic spines of cortical pyramidal neurons in patients with Alzheimer’s disease , 2013, Brain : a journal of neurology.

[2]  E. Hol,et al.  Cortical beta amyloid protein triggers an immune response, but no synaptic changes in the APPswe/PS1dE9 Alzheimer's disease mouse model , 2013, Neurobiology of Aging.

[3]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[4]  A. Hofman,et al.  Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.

[5]  C. Dalgard,et al.  Controlled Cortical Impact and Craniotomy Induce Strikingly Similar Profiles of Inflammatory Gene Expression, but with Distinct Kinetics , 2012, Front. Neur..

[6]  L. Ferrucci,et al.  Correspondence between in vivo 11C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques , 2012, Acta Neuropathologica.

[7]  Stefan Platzer,et al.  Small-Animal PET Imaging of Amyloid-Beta Plaques with [11C]PiB and Its Multi-Modal Validation in an APP/PS1 Mouse Model of Alzheimer's Disease , 2012, PloS one.

[8]  A. Ramasamy,et al.  Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies , 2011, Journal of neurochemistry.

[9]  Daniel R. Salomon,et al.  Strategies for aggregating gene expression data: The collapseRows R function , 2011, BMC Bioinformatics.

[10]  J. Hardy,et al.  Alzheimer's disease genetics: lessons to improve disease modelling. , 2011, Biochemical Society transactions.

[11]  J. Richardson,et al.  The pathology of APP transgenic mice: a model of Alzheimer's disease or simply overexpression of APP? , 2009, Histology and histopathology.

[12]  I. Bechmann,et al.  TREM2 is upregulated in amyloid plaque‐associated microglia in aged APP23 transgenic mice , 2008, Glia.

[13]  Ajit Varki,et al.  Human uniqueness: genome interactions with environment, behaviour and culture , 2008, Nature Reviews Genetics.

[14]  Bin Zhang,et al.  Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R , 2008, Bioinform..

[15]  J. Richardson,et al.  Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease. , 2008, Histology and histopathology.

[16]  M. Gadjeva,et al.  C1q and its growing family. , 2007, Immunobiology.

[17]  Andy M. Yip,et al.  Gene network interconnectedness and the generalized topological overlap measure , 2007, BMC Bioinformatics.

[18]  S. Horvath,et al.  Conservation and evolution of gene coexpression networks in human and chimpanzee brains , 2006, Proceedings of the National Academy of Sciences.

[19]  S. Horvath,et al.  Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target , 2006, Proceedings of the National Academy of Sciences.

[20]  D. Bozyczko‐Coyne,et al.  Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease , 2006, Neurobiology of Aging.

[21]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Horvath,et al.  Statistical Applications in Genetics and Molecular Biology , 2011 .

[23]  J. Quinn,et al.  Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. , 2004, Human molecular genetics.

[24]  Dietmar Rudolf Thal,et al.  Neurodegeneration in normal brain aging and disease. , 2004, Science of aging knowledge environment : SAGE KE.

[25]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[26]  J. Barnes,et al.  Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer’s disease , 2003, Neuroscience.

[27]  J. Loring,et al.  Selectively Reduced Expression of Synaptic Plasticity-Related Genes in Amyloid Precursor Protein + Presenilin-1 Transgenic Mice , 2003, The Journal of Neuroscience.

[28]  Jeffrey A. Johnson,et al.  Lack of Neurodegeneration in Transgenic Mice Overexpressing Mutant Amyloid Precursor Protein Is Associated with Increased Levels of Transthyretin and the Activation of Cell Survival Pathways , 2002, The Journal of Neuroscience.

[29]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[30]  B. Strooper,et al.  Presenilin-1 deficiency leads to loss of Cajal–Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly , 1999, Current Biology.

[31]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[32]  B. Hyman,et al.  Microglial response to amyloid plaques in APPsw transgenic mice. , 1998, The American journal of pathology.

[33]  B. Winblad,et al.  A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid , 1992, Nature Genetics.